Vontobel Holding Ltd. Sells 8,997 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Vontobel Holding Ltd. trimmed its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 40.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,365 shares of the company's stock after selling 8,997 shares during the quarter. Vontobel Holding Ltd.'s holdings in HealthEquity were worth $1,282,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of HQY. UMB Bank n.a. raised its holdings in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after acquiring an additional 164 shares during the last quarter. Quarry LP raised its stake in shares of HealthEquity by 418.8% in the third quarter. Quarry LP now owns 1,349 shares of the company's stock worth $110,000 after purchasing an additional 1,089 shares during the last quarter. 1620 Investment Advisors Inc. purchased a new position in shares of HealthEquity in the third quarter worth $112,000. GAMMA Investing LLC lifted its holdings in shares of HealthEquity by 32.9% during the fourth quarter. GAMMA Investing LLC now owns 1,248 shares of the company's stock valued at $120,000 after purchasing an additional 309 shares in the last quarter. Finally, Covestor Ltd boosted its position in shares of HealthEquity by 27.4% during the third quarter. Covestor Ltd now owns 1,524 shares of the company's stock valued at $125,000 after buying an additional 328 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on HQY. Mizuho started coverage on HealthEquity in a research report on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 target price for the company. JMP Securities increased their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a research report on Tuesday, December 10th. Bank of America lifted their target price on shares of HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a research report on Wednesday, November 13th. The Goldman Sachs Group assumed coverage on HealthEquity in a research note on Friday, November 15th. They issued a "neutral" rating and a $108.00 price target on the stock. Finally, BTIG Research upped their price objective on HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research report on Thursday, November 14th. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $110.71.

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now owns 78,219 shares in the company, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the firm's stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares of the company's stock, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 39,000 shares of company stock valued at $3,895,788. Corporate insiders own 2.20% of the company's stock.

HealthEquity Price Performance

Shares of HQY stock traded down $3.12 on Friday, hitting $108.60. 587,767 shares of the stock traded hands, compared to its average volume of 731,005. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59. The firm has a 50 day simple moving average of $103.66 and a two-hundred day simple moving average of $92.05. The firm has a market cap of $9.41 billion, a price-to-earnings ratio of 99.63, a PEG ratio of 1.63 and a beta of 0.55.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts' consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the prior year, the firm earned $0.40 EPS. As a group, equities research analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.